Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02008877 : Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
PhasePhase 1/Phase 2
AgesMin: 16 Years Max: N/A
Eligibility
Inclusion Criteria:

- Patients ? 16 years old

- Patients with unresectable or metastatic histologically confirmed sporadic or NF1
associated high grade MPNST

- Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2

- Patients must have at least 1 measurable tumor

- Patients must have fully recovered from the acute toxic effects of all prior
anti-cancer therapy (toxicity < grade 2)

- Must be able to swallow whole pills

- Adequate organ function

- Normal fasting cholesterol and triglycerides

- May be on cholesterol medications

Exclusion Criteria:

- Patients receiving current treatment with corticosteroids or another
immunosuppressive. Topical or inhaled corticosteroids are allowed.

- Uncontrolled brain or leptomeningeal metastases, including patients who continue to
require glucocorticoids for brain or leptomeningeal metastases

- Symptomatic congestive heart failure

- Severely impaired lung function

- Significant vascular disease

- Uncontrolled diabetes

- Active (acute or chronic) or uncontrolled severe infections hepatitis

- Impairment of gastrointestinal function

- Patients with an active, bleeding diathesis or significant coagulopathy

- Use of cytochrome P450 isoenzyme 3A4 (CYP3A4)/ CYP2C19 substrates
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02008877      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740